Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Raytheon (RTX) Wins $113M Deal to Support MK 15 CIWS
Raytheon Technologies Corp.’s RTX business segment, Missiles and Defense, recently clinched a modification contract for MK 15 close-in weapon system (CIWS). The award has been
We Did The Math VOO Can Go To $416
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against
Wireless/broadband convergence ‘becoming destructive to all’
© Reuters. Wireless/Broadband convergence ‘becoming destructive to all’ – KeyBanc By Senad Karaahmetovic KeyBanc analysts made a series of rating moves in the broker’s research
Unusual Put Option Trade in JPMorgan Chase (JPM) Worth $1,437.54K
On April 3, 2023 at 10:37:39 ET an unusually large $1,437.54K block of Put contracts in JPMorgan Chase & (JPM) was bought, with a strike
Daily Markets: Markets Re-assess Inflation Pressure, Wait for March Wage Data
Today’s Big Picture Asia-Pacific equity markets finished the day up except for Hong Kong’s Hang Seng, which fell 0.66%, led by Consumer Durables. Australia’s ASX
Analysts Anticipate VOOV To Hit $161
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against
JPM expects a reversal in risk sentiment, stocks to re-test 2022 lows By Investing.com
© Reuters. JPM’s Kolanovic expects a reversal in risk sentiment, stocks to re-test 2022 lows By Senad Karaahmetovic Analysts at JPMorgan, reiterated their cautious stance
Unusual Put Option Trade in Cameco (CCJ) Worth $466.26K
On April 3, 2023 at 10:35:20 ET an unusually large $466.26K block of Put contracts in Cameco (CCJ) was bought, with a strike price of
Y-mAbs Therapeutics, Inc. (YMAB) Surges 13.8%: Is This an Indication of Further Gains?
Y-mAbs Therapeutics, Inc. YMAB shares soared 13.8% in the last trading session to close at $5.70. The move was backed by solid volume with far
Pfizer, Merck trim prices in China for Paxlovid, molnupiravir
© Reuters. FILE PHOTO: Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. REUTERS/Wolfgang